You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 51 No. 3, March 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observations
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Development of Neurologic Symptoms in a Patient With Asymptomatic Wilson's Disease Treated With Penicillamine

George J. Brewer, MD; Atac Turkay, MD; Vilma Yuzbasiyan-Gurkan, PhD

Arch Neurol. 1994;51(3):304-305.


Abstract

Objective
To report a case of presymptomatic Wilson's disease in a patient who became severely neurologically disabled after treatment with penicillamine and to discuss alternative initial therapy for such patients.

Design
Case report. The patient described is briefly compared with a previously studied group of 13 similar presymptomatic patients who received zinc therapy without any clinical worsening and who have had 3 to 9 years of follow-up.

Setting
Referral hospital.

Patients
The patient was referred to us.

Intervention
The patient had initially been treated with penicillamine.

Main Outcome Measure
The main outcome of interest is permanent neurologic disability, depending on type of initial treatment.

Results
The result of initial penicillamine therapy in the patient described is permanent neurologic disability. This is believed to be due to mobilization and redistribution of hepatic copper causing higher levels of copper in key areas of the brain.

Conclusion
We conclude that penicillamine used as initial therapy, even in patients with neurologically asymptomatic Wilson's disease, increases the risk of inducing permanent neurologic damage.



Author Affiliations

From the Departments of Human Genetics (Drs Brewer, Turkay, and Yuzbasiyan-Gurkan) and Internal Medicine (Dr Brewer), The University of Michigan Medical School, Ann Arbor.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Molecular Diagnosis and Prophylactic Therapy for Presymptomatic Chinese Patients With Wilson Disease
Wu et al.
Arch Neurol 2003;60:737-741.
ABSTRACT | FULL TEXT  

A homesick student
McDonnell and Esmonde
Postgrad. Med. J. 1999;75:375-378.
FULL TEXT  

Penicillamine-Related Neurologic Syndrome in a Child Affected by Wilson Disease With Hepatic Presentation
Porzio et al.
Arch Neurol 1997;54:1166-1168.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.